Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice.

Cotter, Catherine A; Americo, Jeffrey L; Earl, Patricia L; Moss, Bernard

Cotter, Catherine A; Americo, Jeffrey L; Earl, Patricia L; Moss, Bernard.

Afiliação

Cotter CA; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Americo JL; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Earl PL; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Moss B; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. bmoss@nih.gov.

NPJ Vaccines ; 8(1): 47, 2023 Mar 27.

Article em En | MEDLINE | ID: mdl-36973267

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2023 Tipo de documento: Article